NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) ("NurExone" or the "Company") is pleased to announce the formation of a U.S.-based ...
Exo-Top was established under the jurisdiction of the State of Nevada. Basing Exo-Top in the U.S. offers key advantages, including proximity to strategic partners, access to a robust biopharma ...
The patent application, filed under Application Number N2039644, represents a significant step forward in the Company's intellectual property strategy. This milestone highlights Cosmos Health's ...
ISAC encompasses a wide range of interactions between sensing and communication, incorporating not just radar but also other sensors, and leveraging their capabilities for applications such as ...
Stallion India Fluorochemicals’ shares debuted at Rs 120, a 33.3% premium on the exchanges. The IPO received robust 188 times subscription, mainly from non-institutional investors. The company plans ...